Hideki Masaki
Specially appointed Associate Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Organ shortage remains a major challenge in transplantation medicine. Interspecies blastocyst complementation is a promising approach to generate human organs in livestock hosts. However, getting xenogeneic donor cells to engraft and expand at early stages remains challenging. Here we identify an innate immune barrier, wherein host macrophages selectively recognize and eliminate viable xenogeneic donor cells. These events represent a form of phagoptosis and highlight a xenogeneic clearance process that we term xenophagocytosis. We identify the mechanism by which host macrophages selectively phagocytize xenogeneic donor cells: xenogeneic cells display elevated phosphatidylserine, an “eat-me” signal recognized by host macrophages through phagocytic receptor Axl. Xenophagocytosis blockade improves both rat and human donor chimerism in mouse embryos, indicating a conserved mechanism. These findings reveal potential mechanisms by which innate immune cells eliminate xenogeneic cells in early embryogenesis to preserve species integrity and offer improved strategies for generating human organs in livestock.
Year:
2025
The generation of human organs in animals through blastocyst complementation offers a promising solution to the shortage of transplantable organs. While human pluripotent stem cells (hPSCs) can contribute to interspecies chimaeric embryos when injected into preimplantation embryos of mice, pigs, or monkeys, their integration is often limited due to low chimaerism and segregation from host tissues, significantly impeding progress toward exogenic organ generation. Here, we demonstrate that co-overexpression of the anti-apoptotic gene BCL2 and the proto-oncogene MYCL , along with various cell cycle regulators significantly enhances human cell chimaerism by promoting cell proliferation. This strategy facilitates the generation of viable mouse pups containing hPSC-derived tissues without tumorigenesis. scRNA-seq analysis revealed that hPSCs already exit pluripotent by early post-implantation stage yet hPSCs with enhanced proliferation were able to integrate effectively into the cardiomyocytes and vasculature of both embryonic and extraembryonic tissues with gene expression profiles reflecting their structural integration. These findings highlight the critical role of cell cycle regulation in overcoming xenogeneic barriers. Our findings offer new insights into strategies for enhancing interspecies organogenesis and advancing the field of regenerative medicine. Highlight Enhancing hPSC proliferation increases human cell contribution in interspecies chimaeras Achieving the generation of viable human-mouse chimaeras without tumour formation hPSCs in post-implantation mouse epiblast exit pluripotency but retain the capacity to integrate into mouse embryogenesis hPSCs derivatives integrate into vasculature and cardiac tissues with lineage-matched transcriptional profiles
Year:
2025
Collaborators (6)
Ayaka Yanagida
Assistant Professor
University of Tokyo
Hiroshi Nagashima
Meiji University
Masashi Miyauchi
Staff Scientist
Stanford University
Joydeep Bhadury
Senior Research Scientist
Stanford University
Hiromitsu Nakauchi
Distinguished Professor
Tokyo Medical and Dental University
Eiji Mizutani
Associate Professor
University of Tsukuba
Make your next move.
Prepare your application
Review drafts before you send them.